PHARMAKINETICS LABORATORIES INC

PHARMAKINETICS LABORATORIES INC., operating within the Services-Testing Laboratories (SIC 8734) universe, delivers specialized analytical and bioequivalence testing services that support pharmaceutical and biotechnology companies navigating complex product life cycles; these core offerings encompass controlled clinical trials, formulation analytics, and regulatory documentation support for clients needing quality assurance in a highly regulated landscape. The company markets its laboratory expertise to drug developers, contract research organizations, and medical device firms that require precise pharmacokinetic studies and bioanalytical data to satisfy FDA, EMA, and other global standards, with particular emphasis on the rigor expected of independent testing laboratories in the late-1990s bioscience boom. Material risks stem from dependence on regulatory approvals, the need to maintain GLP/21 CFR Part 11 compliance, and the potential for revenue volatility tied to client study pipelines, all factors investors should connect to the latest publicly available disclosures such as the Form 10-Q filed Nov 1999; CIK 351506. View live SEC filings on Earnings Feed to stay current.

Source: Earnings Feed research · last updated 11/24/2025